Skip to main content

Table 2 Group mean (minimum – maximum) visual lameness scores based on summation of standing and walking lameness scores in untreated control dogs, or in dogs treated with either firocoxib or grapiprant

From: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs

Time (hours post induction) Control Firocoxib Grapiprant
Experiment 1 - treatments administered 2 h prior to induction of arthritis
 0 (pre-arthritis induction) 0 (0–0) 0 (0–0) 0 (0–0)
 1.5 2 (0–5) 0 (0–2) 2 (0–5)
 3 5 (5–5) 0 (0–3) 4 (1–5)
 5 5 (5–5) 0 (0–0) 5 (5–5)
 7 5 (5–5) 0 (0–0) 5 (4–5)
 10 5 (5–5) 0 (0–0) 4 (1–5)
Experiment 2 - treatments administered 14 h prior to induction of arthritis
 0 (pre-arthritis induction) 0 (0–0) 0 (0–0) 0 (0–0)
 1.5 5 (4–5) 2 (0–5) 2 (0–5)
 3 5 (5–5) 3 (0–5) 5 (4–5)
 5 5 (5–5) 4 (0–5) 5 (5–5)
 7 5 (5–5) 1 (0–5) 5 (5–5)
 10 4 (0–5) 0 (0–1) 5 (5–5)